Quick Takeaways
- 7. Cooperative Ua Lsp filed SCHEDULE 13D/A for Evommune, Inc. Common Stock, $0.0001 par value per share (EVMN).
- Disclosed ownership: 15%.
- Date of event: 12 Feb 2026.
7. Cooperative Ua Lsp - 12 Feb 2026 SCHEDULE 13D/A Report for Evommune, Inc. Common Stock, $0.0001 par value per share (EVMN)
- Filing Manager
- 7. Cooperative Ua Lsp
- Reporting Manager
- LSP 7 Cooperatieve U.A.
- Symbol
- EVMN
- Shares outstanding
- 35,974,918 shares
- Disclosed Ownership
- 5,288,313 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13D/A
- Filing time
- 19 Feb 2026, 16:30:02 UTC
- Date of event
- 12 Feb 2026
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"7. Cooperative Ua Lsp disclosed 15% ownership in Evommune, Inc. Common Stock, $0.0001 par value per share (EVMN) on 12 Feb 2026."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 19 Feb 2026, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LSP 7 Cooperatieve U.A. | 15% | 5,288,313 | 0 | 5,288,313 | By: LSP 7 Management B.V., its sole director, By: /s/ Martijn Kleijwegt | Martijn Kleijwegt, Managing Director | 0001876264 |
| LSP 7 Management B.V. | 15% | 5,288,313 | 0 | 5,288,313 | /s/ Martijn Kleijwegt | Martijn Kleijwegt, Managing Director |